Risk Factors, Prevention, and Early Disease

Concurrent Session 1

Date: Friday, April 25, 2025
Time: 8:45 AM to 10:15 AM

Description

Moderators

Yong In  

Brooke Patterson

8:45 AM - 9:25 AM

Early OA, What Should This Include?

Grace Lo

9:25 AM - 9:35 AM

013: METFORMIN FOR KNEE OSTEOARTHRITIS WITH OVERWEIGHT OR OBESITY: A COMMUNITY-BASED RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Flavia Cicuttini

9:35 AM - 9:45 AM

014: TOOLS FOR ENDOTYPING OSTEOARTHRITIS SYNOVIAL FLUID BASED ON SIS-INDUCIBLE ELEMENT AND ACTIVATOR PROTEIN 1-RESPONSE ELEMENT TRANSCRIPTOR REPORTER ASSAYS

Marjolein Caron

9:45 AM - 9:55 AM

015: EFFICACY OF A WEIGHT LOSS INTERVENTION ON HIP OSTEOARTHRITIS PAIN: A RANDOMISED CONTROLLED TRIAL

Michelle Hall

9:55 AM - 10:05 AM

016: ASSOCIATION OF MAGNETIC RESONANCE IMAGING BIOMARKERS WITH WOMAC SCORES AND SUBSEQUENT KNEE ARTHROPLASTY

Stephanie Jo

10:05 AM - 10:07 AM

017: RELATIONSHIP BETWEEN KNEE CARTILAGE THICKNESS AND CONCENTRATIONS OF BIOMARKERS OF MATRIX METABOLISM AND JOINT SPECIFIC INFLAMMATION AFTER ACL INJURY – A LONGITUDINAL STUDY

Staffan Larsson

10:07 AM - 10:09 AM

018: VISCOELASTIC PROPERTIES OF HUMAN COLLATERAL KNEE LIGAMENTS ARE RELATED AND ALTERED IN OSTEOARTHRITIS

Adam Kositsky

10:09 AM - 10:11 AM

019: ASSOCIATION OF THIGH INTRAMUSCULAR FAT INFILTRATION WITH INCIDENT KNEE AND HIP OSTEOARTHRITIS: A LONGITUDINAL UK BIOBANK COHORT STUDY

Qianlin Weng

10:11 AM - 10:13 AM

020: EFFECT OF WEIGHT LOSS AND LIRAGLUTIDE ON NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN LEVELS AMONG INDIVIDUALS WITH OVERWEIGHT AND KNEE OSTEO-ARTHRITIS: SECONDARY ANALYSES OF A RANDOMIZED CONTROLLED TRIAL

Asbjørn Seenithamby Poulsen

10:13 AM - 10:15 AM Q & A
  • Early OA, What Should This Include?

    Description

    Review the current literature surrounding the multiple definitions of Early OA, their purposes, and encourage discussion regarding which definition(s) are the most useful and why.

    Speakers